Kishi S, Kadoya H, Kashihara N
Nat Rev Nephrol. 2024; 20(9):586-602.
PMID: 38977884
DOI: 10.1038/s41581-024-00854-w.
Dahmke H, Schelshorn J, Fiumefreddo R, Schuetz P, Salili A, Cabrera-Diaz F
Drugs Real World Outcomes. 2024; 11(1):125-135.
PMID: 38183571
PMC: 10928054.
DOI: 10.1007/s40801-023-00405-y.
Mori T, Yano T, Yoshioka K, Miyazaki Y
J Cardiovasc Dev Dis. 2023; 10(9).
PMID: 37754834
PMC: 10532343.
DOI: 10.3390/jcdd10090405.
Akimoto H, Hayakawa T, Nagashima T, Minagawa K, Takahashi Y, Asai S
Front Pharmacol. 2023; 14:1176096.
PMID: 37288110
PMC: 10242015.
DOI: 10.3389/fphar.2023.1176096.
Calvo Barbado D, Saiz Fernandez L, Leache Alegria L, Celaya Lecea M, Gutierrez-Valencia M
F1000Res. 2023; 11:496.
PMID: 36761833
PMC: 9889944.
DOI: 10.12688/f1000research.109987.2.
Hospitalisations Related to the Combination of ACE Inhibitors and/or Angiotensin Receptor Blockers with Diuretics and NSAIDs: A Post Hoc Analysis on the Risks Associated with Triple Whammy.
Mattioli I, Bettiol A, Crescioli G, Bonaiuti R, Mannaioni G, Vannacci A
Healthcare (Basel). 2023; 11(2).
PMID: 36673605
PMC: 9858958.
DOI: 10.3390/healthcare11020238.
A Four-Year Report on Renal Outcomes Following the Elective Withdrawal of Long-Term Renin-Angiotensin-Aldosterone Blockade in a Cohort of Patients With Otherwise Inexplicable New-Onset and Progressive Acute Kidney Injury.
Onuigbo M
Cureus. 2022; 14(10):e30794.
PMID: 36447726
PMC: 9701493.
DOI: 10.7759/cureus.30794.
Evaluation of Phytochemistry and Pharmacological Properties of .
Sajid M, Khan M, Ijaz M, Ismail H, Bhatti M, Shah S
Molecules. 2022; 27(14).
PMID: 35889458
PMC: 9320741.
DOI: 10.3390/molecules27144582.
Drug-Related Problems and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study.
Diez R, Cadenas R, Susperregui J, Sahagun A, Fernandez N, Garcia J
Int J Environ Res Public Health. 2022; 19(7).
PMID: 35409994
PMC: 8998432.
DOI: 10.3390/ijerph19074313.
Time until onset of acute kidney injury by combination therapy with "Triple Whammy" drugs obtained from Japanese Adverse Drug Event Report database.
Kunitsu Y, Hira D, Morikochi A, Ueda T, Isono T, Morita S
PLoS One. 2022; 17(2):e0263682.
PMID: 35139129
PMC: 8827454.
DOI: 10.1371/journal.pone.0263682.
Community prescribing of potentially nephrotoxic drugs and risk of acute kidney injury requiring renal replacement therapy in critically ill adults: A national cohort study.
Tominey S, Timmins A, Lee R, Walsh T, Lone N
J Intensive Care Soc. 2021; 22(2):102-110.
PMID: 34025749
PMC: 8120571.
DOI: 10.1177/1751143719900099.
Nephrotoxicity of Herbal Products in Europe-A Review of an Underestimated Problem.
Kilis-Pstrusinska K, Wiela-Hojenska A
Int J Mol Sci. 2021; 22(8).
PMID: 33923686
PMC: 8074082.
DOI: 10.3390/ijms22084132.
Non-steroidal anti-inflammatory drugs (NSAIDs) for trigger finger.
Leow M, Zheng Q, Shi L, Tay S, Chan E
Cochrane Database Syst Rev. 2021; 4:CD012789.
PMID: 33849080
PMC: 8094914.
DOI: 10.1002/14651858.CD012789.pub2.
Analgesic and Antipyretic Activities of Ethyl Acetate Fraction Tablet of in Animal Models.
Ilmi H, Pamungkas I, Tumewu L, Hafid A, Widyawaruyanti A
Evid Based Complement Alternat Med. 2021; 2021:8848797.
PMID: 33747115
PMC: 7960022.
DOI: 10.1155/2021/8848797.
Pathophysiological mechanisms underlying a rat model of triple whammy acute kidney injury.
Prieto-Garcia L, Vicente-Vicente L, Blanco-Gozalo V, Hidalgo-Thomas O, Garcia-Macias M, Kurtz A
Lab Invest. 2020; 100(11):1455-1464.
PMID: 32719543
DOI: 10.1038/s41374-020-0473-9.
Nonsteroidal Anti-inflammatory Drugs Utilization Patterns and Risk of Adverse Events due to Drug-Drug Interactions among Elderly Patients: A Study from Jordan.
Al-Azayzih A, Al-Azzam S, Alzoubi K, Jarab A, Kharaba Z, Al-Rifai R
Saudi Pharm J. 2020; 28(4):504-508.
PMID: 32273811
PMC: 7132832.
DOI: 10.1016/j.jsps.2020.03.001.
Drug-Induced Acute Kidney Injury: A Standardized Patient Case for Clerkship Students.
Kramer R, Karpa K
MedEdPORTAL. 2019; 13:10553.
PMID: 30800755
PMC: 6342158.
DOI: 10.15766/mep_2374-8265.10553.
Frequency and Associations of Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients With a Musculoskeletal Disorder and Hypertension, Heart Failure, or Chronic Kidney Disease.
Bouck Z, Mecredy G, Ivers N, Barua M, Martin D, Austin P
JAMA Intern Med. 2018; 178(11):1516-1525.
PMID: 30304456
PMC: 6248204.
DOI: 10.1001/jamainternmed.2018.4273.
Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy.
Kongara K, Chambers J
Vet Med (Auckl). 2018; 9:53-61.
PMID: 30148083
PMC: 6101027.
DOI: 10.2147/VMRR.S170893.
Pharmacovigilance and expedited drug approvals.
Linger M, Martin J
Aust Prescr. 2018; 41(2):50-53.
PMID: 29670312
PMC: 5895470.
DOI: 10.18773/austprescr.2018.010.
